MicroPort Scientific (HKG:0853) said it was considering consolidating its cardiac rhythm management business with MicroPort CardioFlow Medtech (HKG:2160), according to a Hong Kong bourse filing Wednesday.
Shares of MicroPort CardioFlow gained 9% in morning trade Thursday, while MicroPort Scientific rose nearly 5%.
Under the proposal, MicroPort's CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversee's the group's structural heart disease business.
MicroPort Scientific cautioned that the proposal was non-binding and subject to a number of conditions.
Meanwhile, MicroPort CardioFlow said it was evaluating the proposal and would inform the market with relevant updates.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。